LASIK marketing often sells the absence of something: no glasses, no contacts, no inconvenience. That emotional promise is simple. The actual decision is not.
Refractive surgery permanently changes the cornea, candidacy is individualized, devices have specific approved ranges, and outcomes and adverse effects vary. The job of marketing is to make an appropriate evaluation easier to understand—not to make surgery feel inevitable.
This article concerns marketing, not clinical guidance. A qualified ophthalmologist should own medical accuracy, eligibility protocols, risk communication, and updates to patient-facing content.
The offer is an evaluation
“Book LASIK” collapses several decisions into one button. A more accurate pathway begins with an evaluation that determines whether LASIK, another option, continued glasses or contacts, or no elective procedure is appropriate.
The page should explain what the evaluation may include, whether contact-lens cessation is required in advance, who performs the examination, when the surgeon becomes involved, and what records or health information matter. FDA patient guidance says a baseline evaluation should address candidacy, risks, benefits, alternatives, expectations, and patient responsibilities.
The call to action should match that reality: “Request a refractive surgery evaluation” is clearer than “Start life without glasses.” The latter can imply both candidacy and an outcome the practice cannot know.
Name the qualification and the technology precisely
State the surgeon’s board certification, training, and relevant procedure experience in verifiable terms. Avoid “top,” “best,” or “most experienced” unless the comparison is defined and substantiated.
“FDA approved LASIK” is also incomplete. FDA approves specific laser systems for particular treatment ranges and provides patient labeling. A practice, surgeon, package, or individual outcome does not become FDA approved because an approved device is used. Confirm the current device, indication, and labeling before publication.
This distinction belongs to the wider FTC and FDA healthcare advertising framework: identify the product, speaker, jurisdiction, express claim, implied claim, and evidence before approving copy.
Risk belongs near the promise
FDA materials ask prospective patients to consider risks and limitations including dry eye, glare, halos, starbursts, night-driving difficulty, under- or over-treatment, possible need for additional surgery, and the possibility of still needing glasses. The relevance and frequency of risks require current clinical review and product-specific context.
A footer link titled “Important information” does not necessarily correct a homepage promising “perfect vision forever.” The FTC evaluates net impression and whether disclosures are clear and conspicuous. The first move is to narrow an overbroad claim, not to add smaller type.
Before-and-after style visuals need equal care. Refractive surgery marketing may use patient stories, prescription changes, lifestyle scenes, or simulations of visual symptoms. Follow the permission and claims disciplines in before-and-after photo compliance. A simulation should be labeled and clinically reviewed; a testimonial cannot establish what others should expect.
A worked page: the glasses-free package
Imagine a practice advertising “20/20 by tomorrow—LASIK from $99 per month.” The landing page uses a beach image, a short form, and a countdown. Device, surgeon, candidacy, risk, total cost, financing conditions, and evaluation are difficult to find.
The revised page begins with the evaluation and explains that outcomes vary. It identifies the surgeon and technology accurately, links to relevant FDA patient information, discusses meaningful risks and alternatives in readable language, and states that the consultation may lead to another recommendation or no procedure.
Pricing shows what is included and what can change the estimate. Financing identifies the lender and material terms as required; approval is not presented as clinical eligibility. The practice removes the artificial countdown and tells visitors when they can expect a response.
That is still conversion-oriented. It converts uncertainty into an informed next step rather than converting pressure into a form fill.
Recovery content should describe ranges and ownership
“Back to normal the next day” may be true for some activities or patients and misleading as a universal recovery claim. Explain that recovery and restrictions vary, identify the approved source of instructions, and tell patients whom to contact with concerns.
Marketing should not improvise urgent clinical advice. It can make the escalation path visible: the appropriate practice number, after-hours process, and emergency instruction approved by the care team.
The experience after inquiry is part of the promise. The premium healthcare brand is built through clear access, calm explanation, and reliable follow-up—not luxury cues alone.
Paid search should not outrun capacity
High-intent LASIK queries can produce demand quickly. Campaigns should separate information-seeking, brand, location, cost, and evaluation intent where useful, with landing pages that continue the actual promise.
Apply the broader healthcare website conversion framework: answer what brought the visitor, resolve the next uncertainty, minimize sensitive form data, and measure downstream appointment quality. Google’s health-sensitive advertising policies and applicable privacy law need separate review.
Do not treat every call as a candidate or every scheduled evaluation as a procedure. Track connected inquiries, appropriate evaluations, attendance, decisions, and reasons for non-fit without pressuring the clinical team to produce a target conversion rate.
Maintain a claim and content file
For each meaningful claim, preserve the exact wording, implied message, evidence, device or population specificity, clinical approval, legal review where warranted, channel, and expiration. Re-review when FDA information, device use, pricing, financing, surgeon affiliation, or platform policy changes.
Patient stories require valid permission, honest editing, typicality analysis, material-connection disclosure, and a use registry. Platform acceptance does not prove legal compliance.
Clarity is not anti-growth
People considering LASIK do not need the website to choose for them. They need it to explain what can be decided online, what requires examination, what risks and alternatives belong in the conversation, and what the next step will cost and involve.
The practice that communicates those limits may sound less dramatic than a glasses-free promise. It also gives the right patient a stronger reason to schedule: not certainty about an outcome, but confidence in the quality of the decision ahead.
Primary sources
Questions this article answers
Can a LASIK practice advertise '20/20 vision'?
Only if the complete claim and implied expectation are supported and appropriately qualified. A headline can mislead if it implies a guaranteed result or freedom from future glasses. Counsel and clinical reviewers should approve it.
What should a LASIK landing page explain?
It should explain that evaluation determines candidacy, identify the surgeon and relevant device facts, discuss meaningful risks and alternatives, set realistic recovery expectations, and clarify price and next steps.
Does FDA approval mean LASIK is right for a patient?
No. FDA approval applies to specific devices and indications. An eye-care professional must evaluate the individual, and approved technology does not guarantee an outcome.
Part of the Becoming the Clear Choice collection
Positioning, proof, content, and patient psychology for practices that need to create preference rather than mere awareness.
Explore the topic hub